The Task-force in Europe for Drug Development for the Young (TEDDY) is a Network of Excellence (NoE) funded in 2005 as a consortium responding to a call published by the European Commission and aimed at “structuring efforts devoted to the development of medicines tailored for children”.
Between 2005-2010, the FP6 TEDDY project (LSHB-CT-2005-005216) played a critical role in the start-up of paediatric activities in Europe, in parallel with the introduction of the new European Paediatric Regulation.
Since 2010 TEDDY has revised its organisation and gathered research centres and groups willing to be engaged in developing clinical research. Today, TEDDY is an independent multidisciplinary, multinational Network composed of partners from 15 countries aimed at facilitating the performance of good quality paediatric studies and research.
TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.
Any research centres and groups willing to be engaged in the development of clinical research can join the TEDDY Network. Find out more.
Latest News
TEDDY Network as EMA stakeholder at the Second International Awareness Session for International regulators, academia and non-governamental organisations
On 8-9 March 2018, the European Medicines Agency (EMA) held “the Second International Awareness Session for international regulators, academia and non-governmental organisations”. The meeting provided the occasion to present an overall overview on
Save the date – “EPTRI: a new European Research Infrastructure to foster the translation research in paediatrics”, April 10th, Bari (Italy)
The next meeting of the ID-EPTRI (European Paediatric Translational Research Infrastructure) project, entitled “EPTRI: una nuova Infrastruttura Europea per favorire la Ricerca Traslazionale in Pediatria” (EPTRI: a new European Research Infrastructure to foster
